Correspondence 0001493152-24-041083 from Greenwich LifeSciences, Inc. (GLSI) (CIK 0001799788) (GLSI)

Greenwich LifeSciences, Inc. (GLSI) (CIK 0001799788)
Date: Oct. 15, 2024 · CIK: 0001799788 · Accession: 0001493152-24-041083

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-282533

Date

October 7, 2024

Author

Not clearly detected

Form

CORRESP

Company

Greenwich LifeSciences, Inc. (GLSI) (CIK 0001799788)

Letter

Greenwich LifeSciences, Inc.

Bluebonnet Dr., Building 14

Stafford, TX 77477

October 15, 2024

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Tim Buchmiller

Re: Greenwich LifeSciences, Inc.

Form S-3 Registration Statement

Filed October 7, 2024

File No. 333-282533

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Greenwich LifeSciences, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 9:00 a.m., Eastern Daylight Time, on Thursday, October 17, 2024, or as soon thereafter as possible.

Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

GREENWICH LIFESCIENCES, INC.

By: /s/ Snehal Patel

Name: Snehal Patel

Title: Chief Executive Officer

-1-

Show Raw Text

CORRESP
1
filename1.htm

Greenwich
LifeSciences, Inc.

3992
Bluebonnet Dr., Building 14

Stafford,
TX 77477

    October
    15, 2024

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, N.E.

Washington,
D.C. 20549

Attention:
Tim Buchmiller

    Re:
    Greenwich
    LifeSciences, Inc.

    Form
    S-3 Registration Statement

    Filed
    October 7, 2024

    File
    No. 333-282533

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Greenwich LifeSciences, Inc. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective
at 9:00 a.m., Eastern Daylight Time, on Thursday, October 17, 2024, or as soon thereafter as possible.

Please
notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible
as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

    GREENWICH
    LIFESCIENCES, INC.

    By:
    /s/
    Snehal Patel

    Name:
    Snehal
    Patel

    Title:
    Chief
    Executive Officer

    -1-

SecProbe.io